| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 10/23/2026 | ±3.4% | -1.1% | over-priced |
| 07/24/2026 | ±3.3% | +1.0% | over-priced |
| 04/24/2026 | ±3.5% | -3.0% | over-priced |
| 02/06/2026 | ±2.3% | +0.5% | over-priced |
| 10/24/2025 | ±3.9% | -0.1% | over-priced |
| 07/25/2025 | ±3.9% | -0.1% | over-priced |
| 04/24/2025 | ±2.7% | +1.2% | over-priced |
| 02/06/2025 | ±1.3% | +10.9% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q3 FY2026 | $2.12 | $11.4B | $3.3B |
| Q2 FY2026 | $1.80 | $11.2B | $2.8B |
| Q1 FY2026 | $1.56 | $10.1B | $2.4B |
| Q4 FY2025 | — | $10.4B | $2.1B |
Philip Morris International Inc. (PM) reports in 87 days, with the next report estimated for 01/22/2027. Across the last 8 reports, options priced an average ±3.0% earnings move while the stock actually moved 2.2% on average — the market has systematically over-priced PM's earnings risk. Fundamentals into the print: EPS down 4.9% year-over-year, revenue up 5.5%. QuantLogix's live 5-factor engine currently reads PM as a buy at 73/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →